---
title: "ESC 2025 hears long-term data from DANGER-SHOCK trial"
date: "2025-09-01T14:21:04.000Z"
publishedDate: "1 septembre 2025"
summary: "Routine use of the Impella CP (Abiomed) micro-axial flow pump in the treatment of patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock leads to an absolute mortality reduction of 16.3% when compared to standard care at 10 years, long-term data from the DANGER-SHOCK trial have shown. These findings from the long-term follow [&#8230;] The post ESC 2025 hears long-term data from DANGER-SHOCK trial appeared first on Cardiovascular News ."
importance: ""
sourceUrl: "https://cardiovascularnews.com/esc-2025-hears-long-term-data-from-danger-shock-trial/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2025-09-01-esc-2025-hears-long-term-data-from-danger-shock-trial"
imageUrl: "http://cardiovascularnews.com/wp-content/uploads/sites/14/2025/08/IMG_4925-scaled.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/esc-2025-hears-long-term-data-from-danger-shock-trial/"
---

![ESC 2025 hears long-term data from DANGER-SHOCK trial](http://cardiovascularnews.com/wp-content/uploads/sites/14/2025/08/IMG_4925-scaled.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/esc-2025-hears-long-term-data-from-danger-shock-trial/*

## L’essentiel

Routine use of the Impella CP (Abiomed) micro-axial flow pump in the treatment of patients with ST-segment elevation myocardial infarction (STEMI) complicated by cardiogenic shock leads to an absolute mortality reduction of 16.3% when compared to standard care at 10 years, long-term data from the DANGER-SHOCK trial have shown. These findings from the long-term follow [&#8230;] The post ESC 2025 hears long-term data from DANGER-SHOCK trial appeared first on Cardiovascular News .

## Lien source

https://cardiovascularnews.com/esc-2025-hears-long-term-data-from-danger-shock-trial/
